285 related articles for article (PubMed ID: 29686048)
1. Fear Memory Recall Potentiates Opiate Reward Sensitivity through Dissociable Dopamine D1 versus D4 Receptor-Dependent Memory Mechanisms in the Prefrontal Cortex.
Jing Li J; Szkudlarek H; Renard J; Hudson R; Rushlow W; Laviolette SR
J Neurosci; 2018 May; 38(19):4543-4555. PubMed ID: 29686048
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D4 receptor transmission in the prefrontal cortex controls the salience of emotional memory via modulation of calcium calmodulin-dependent kinase II.
Lauzon NM; Ahmad T; Laviolette SR
Cereb Cortex; 2012 Nov; 22(11):2486-94. PubMed ID: 22120417
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D1 versus D4 receptors differentially modulate the encoding of salient versus nonsalient emotional information in the medial prefrontal cortex.
Lauzon NM; Bishop SF; Laviolette SR
J Neurosci; 2009 Apr; 29(15):4836-45. PubMed ID: 19369552
[TBL] [Abstract][Full Text] [Related]
4. Opiate exposure and withdrawal induces a molecular memory switch in the basolateral amygdala between ERK1/2 and CaMKIIα-dependent signaling substrates.
Lyons D; de Jaeger X; Rosen LG; Ahmad T; Lauzon NM; Zunder J; Coolen LM; Rushlow W; Laviolette SR
J Neurosci; 2013 Sep; 33(37):14693-704. PubMed ID: 24027270
[TBL] [Abstract][Full Text] [Related]
5. NMDA receptor blockade in the prelimbic cortex activates the mesolimbic system and dopamine-dependent opiate reward signaling.
Tan H; Rosen LG; Ng GA; Rushlow WJ; Laviolette SR;
Psychopharmacology (Berl); 2014 Dec; 231(24):4669-79. PubMed ID: 24871699
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid transmission in the prelimbic cortex bidirectionally controls opiate reward and aversion signaling through dissociable kappa versus μ-opiate receptor dependent mechanisms.
Ahmad T; Lauzon NM; de Jaeger X; Laviolette SR
J Neurosci; 2013 Sep; 33(39):15642-51. PubMed ID: 24068830
[TBL] [Abstract][Full Text] [Related]
7. Supra-normal stimulation of dopamine D1 receptors in the prelimbic cortex blocks behavioral expression of both aversive and rewarding associative memories through a cyclic-AMP-dependent signaling pathway.
Lauzon NM; Bechard M; Ahmad T; Laviolette SR
Neuropharmacology; 2013 Apr; 67():104-14. PubMed ID: 23164618
[TBL] [Abstract][Full Text] [Related]
8. The effects of AMPA receptor blockade in the prelimbic cortex on systemic and ventral tegmental area opiate reward sensitivity.
De Jaeger X; Bishop SF; Ahmad T; Lyons D; Ng GA; Laviolette SR
Psychopharmacology (Berl); 2013 Feb; 225(3):687-95. PubMed ID: 22972411
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid transmission in the prefrontal cortex bi-phasically controls emotional memory formation via functional interactions with the ventral tegmental area.
Draycott B; Loureiro M; Ahmad T; Tan H; Zunder J; Laviolette SR
J Neurosci; 2014 Sep; 34(39):13096-109. PubMed ID: 25253856
[TBL] [Abstract][Full Text] [Related]
10. Inputs from the basolateral amygdala to the nucleus accumbens shell control opiate reward magnitude via differential dopamine D1 or D2 receptor transmission.
Lintas A; Chi N; Lauzon NM; Bishop SF; Sun N; Tan H; Laviolette SR
Eur J Neurosci; 2012 Jan; 35(2):279-90. PubMed ID: 22236063
[TBL] [Abstract][Full Text] [Related]
11. Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in μ-opioid-induced place preference.
Narita M; Matsushima Y; Niikura K; Narita M; Takagi S; Nakahara K; Kurahashi K; Abe M; Saeki M; Asato M; Imai S; Ikeda K; Kuzumaki N; Suzuki T
Addict Biol; 2010 Oct; 15(4):434-47. PubMed ID: 20731628
[TBL] [Abstract][Full Text] [Related]
12. Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.
Chartoff EH; Barhight MF; Mague SD; Sawyer AM; Carlezon WA
Psychopharmacology (Berl); 2009 Jun; 204(2):227-39. PubMed ID: 19148621
[TBL] [Abstract][Full Text] [Related]
13. Identification of a dopamine receptor-mediated opiate reward memory switch in the basolateral amygdala-nucleus accumbens circuit.
Lintas A; Chi N; Lauzon NM; Bishop SF; Gholizadeh S; Sun N; Tan H; Laviolette SR
J Neurosci; 2011 Aug; 31(31):11172-83. PubMed ID: 21813678
[TBL] [Abstract][Full Text] [Related]
14. Prefrontal cortex gates acute morphine action on dopamine neurons in the ventral tegmental area.
Liu C; Fang X; Wu Q; Jin G; Zhen X
Neuropharmacology; 2015 Aug; 95():299-308. PubMed ID: 25882828
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic regulation of inhibitory and excitatory transmission in the basolateral amygdala-prefrontal cortical pathway.
Floresco SB; Tse MT
J Neurosci; 2007 Feb; 27(8):2045-57. PubMed ID: 17314300
[TBL] [Abstract][Full Text] [Related]
16. Opiate-associated contextual memory formation and retrieval are differentially modulated by dopamine D1 and D2 signaling in hippocampal-prefrontal connectivity.
Wang Y; Zhang H; Cui J; Zhang J; Yin F; Guo H; Lai J; Xing B
Neuropsychopharmacology; 2019 Jan; 44(2):334-343. PubMed ID: 29728647
[TBL] [Abstract][Full Text] [Related]
17. NMDA receptor hypofunction in the prelimbic cortex increases sensitivity to the rewarding properties of opiates via dopaminergic and amygdalar substrates.
Bishop SF; Lauzon NM; Bechard M; Gholizadeh S; Laviolette SR
Cereb Cortex; 2011 Jan; 21(1):68-80. PubMed ID: 20392811
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid reward and aversion effects in the posterior ventral tegmental area are mediated through dissociable opiate receptor subtypes and separate amygdalar and accumbal dopamine receptor substrates.
Ahmad T; Laviolette SR
Psychopharmacology (Berl); 2017 Aug; 234(15):2325-2336. PubMed ID: 28669034
[TBL] [Abstract][Full Text] [Related]
19. Dopamine Neurotransmission in the Ventral Tegmental Area Promotes Active Forgetting of Cocaine-Associated Memory.
Castillo Díaz F; Hernandez MA; Capellá T; Medina JH
Mol Neurobiol; 2019 Sep; 56(9):6206-6217. PubMed ID: 30739236
[TBL] [Abstract][Full Text] [Related]
20. Opiate Exposure State Controls a D2-CaMKIIα-Dependent Memory Switch in the Amygdala-Prefrontal Cortical Circuit.
Rosen LG; Zunder J; Renard J; Fu J; Rushlow W; Laviolette SR
Neuropsychopharmacology; 2016 Feb; 41(3):847-57. PubMed ID: 26174594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
